Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07611422
Recruiting Not applicable

Showers and Stress

NCT07611422 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2026-05-10
Last updated
2026-05-28

Condition(s) studied

Healthy Volunteers

Investigational drug(s) / intervention(s)

Positive expectation about the effects of cold and warm showersNo expectation regarding the exposure to cold water and/or to warm showers

Positive expectation about the effects of cold and warm showers: Partecipants will be exposed to positive information about the effects of warm and cold showers using a 2x2 factorial design

No expectation regarding the exposure to cold water and/or to warm showers: Partecipants will be exposed neutral information about the effects of warm and cold showers using a 2x2 factorial design

Study summary

The study investigates whether repeated exposure to cold showers can improve the ability to cope with and respond to stress. In particular, it examines both the psychophysiological effects of cold showers and the role of expectations regarding their effectiveness. The research adopts a 2×2 experimental design with approximately 120 healthy adults, randomly assigned to either an experimental group or a control group, and further divided based on the presence or absence of information emphasizing the potential benefits of the intervention. The experimental group takes warm or lukewarm showers with a final 30-second exposure to cold water at least four times per week, while the control group takes only warm or lukewarm showers. In parallel, some participants receive positive information about the effectiveness of the intervention for stress management, while others receive no specific information. At baseline and at the end of the study, participants complete questionnaires assessing perceived stress, psychological well-being, and quality of life, along with a physiological measure and a cognitive stress task (Stroop test with heart rate monitoring). During the four-week intervention period, participants keep a daily diary recording shower habits and perceived stress levels.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria Participants will be eligible for the study if they meet the following criteria: * Age ≥ 18 years * Good general health status, self-reported and/or certified by a medical document (e.g., general medical certificate or sports medical clearance) * Willingness to participate for the full duration of the study (4 weeks) * Ability to understand and independently complete questionnaires and study diaries * Signed informed consent Exclusion Criteria Participants will be excluded from the study if they present: * Uncompensated cardiovascular, neurological, or endocrine conditions considered relevant to stress or cold exposure tolerance * Medical conditions contraindicating cold exposure (e.g., Raynaud's phenomenon, cold urticaria, etc.) * Pregnancy * Use of medications that may interfere with stress responses (e.g., beta-blockers, anxiolytics, systemic corticosteroids) * Acute or unstable psychiatric disorders * Inability to comply with the experimental protocol or complete study materials * Concurrent participation in other studies involving stress or physiological regulation interventions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Università Cattolica del Sacro Cuore Milan Italy Recruiting

More Catholic University of the Sacred Heart trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07611422 on ClinicalTrials.gov ↗ ← All trials in Italy